All In MedTech

Device Trial Radar · NCT03807661

Percutaneous Deep Vein Arterialization Post-Market Study

Last checked: Nov 19, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

28

Actual

Start

Dec 11, 2019

Primary completion

Oct 9, 2023

Study completion Oct 28, 2024

Sponsor

Lead sponsor
LimFlow SANot on our public-company list
Sponsor type
Industry
First posted
Jan 17, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 21 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this post-market study is to evaluate the safety and effectiveness of the LimFlow System in creating a below-the-knee arterio-venous fistula for venous arterialization in subjects with critical limb ischemia.

Conditions

  • Critical Limb Ischemia

Interventions

  • Percutaneous deep vein arterializationProcedure

    Creation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach

  • LimFlow SystemDevice

    Creation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Amputation-free SurvivalTime frame: Throughout one year

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • North Bristol NHS Trust

    Bristol, United Kingdom

  • Glenfield Hospital

    Leicester, United Kingdom

  • Royal Liverpool and Broadgreen University Hospitals NHS Trust

    Liverpool, United Kingdom

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.